Moderate-to-Severe Crohn’s Disease: Pharmacologic Management Guidelines Pocket Guide - Guideline Central

Moderate-to-Severe Crohn’s Disease: Pharmacologic Management

American Gastroenterological AssociationPublished: February 9, 2026

  • Key Points
  • Treatment
  • Figures:
    • Use and Positioning of Advanced Therapies in the Management of Adult Outpatients With Moderate-to-Severely Active CD
    • Use of Combination Therapy and Immunomodulator Therapy, and De-escalation of Therapy in the Management of Adult Outpatients With Moderate-To-Severely Active CD


You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.